This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohta, K. Articles by Iwao, H. Search for Related Content PubMed PubMed Citation Articles by Ohta, K. Articles by Iwao, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure

(Hypertension. 1996;28:627-634.)
© 1996 American Heart Association, Inc.

Articles

Role of Angiotensin-Converting Enzyme, Adrenergic Receptors, and Blood Pressure in Cardiac Gene Expression of Spontaneously Hypertensive Rats During Development

Kensuke Ohta; Shokei Kim; Hiroshi Iwao

the Department of Pharmacology, Osaka (Japan) City University Medical School.

Correspondence to Shokei Kim, MD, Department of Pharmacology, Osaka City University Medical School, 1-4-54 Asahimachi, Abenoku, Osaka 545, Japan.

We undertook this study to investigate the regulatory mechanism of cardiac gene expression in spontaneously hypertensive rats (SHR) during development. We measured cardiac mRNAs by Northern blot analysis. In 9-week-old SHR at the very early stage of cardiac hypertrophy, the expression of various cardiac genes related to the regulation of cardiac contraction and relaxation was already significantly changed compared with control Wistar-Kyoto rats, indicating that cardiac molecular changes are responsible for cardiac remodeling or the modulation of cardiac performance in SHR. We gave various types of antihypertensive drugs, at oral doses causing a mild and comparable hypotensive effect, to 27-week-old SHR to examine the effects on the altered cardiac gene expression. Imidapril, an angiotensin-converting enzyme inhibitor, normalized the increased gene expression of atrial natriuretic polypeptide and collagen types I and III and the decreased expression of -myosin heavy chain in SHR heart. Atenolol (a ß₁-blocker) combined with doxazosin did not affect cardiac ANP and -myosin heavy chain expression of SHR but normalized the increased collagen expression. In contrast, despite a hypotensive effect comparable to these two drug treatments, doxazosin (an ₁-blocker) alone or manidipine (a calcium antagonist) did not normalize these altered gene expressions of SHR. These results show that the cardiac renin-angiotensin system is involved in the altered cardiac gene expression in SHR. The ß₁- but not ₁-adrenergic receptor is also responsible for the increased cardiac collagen expression in SHR.

Key Words: hypertrophy • angiotensin-converting enzyme • receptors, adrenergic • aging • hypertension, genetic

This article has been cited by other articles:

				C. Cerutti, M. Kurdi, G. Bricca, W. Hodroj, C. Paultre, J. Randon, and M.-P. Gustin Transcriptional alterations in the left ventricle of three hypertensive rat models Physiol Genomics, November 21, 2006; 27(3): 295 - 308. [Abstract] [Full Text] [PDF]

				S. Bartel, B. Hoch, D. Vetter, and E.-G. Krause Expression of Human Angiotensinogen-Renin in Rat: Effects on Transcription and Heart Function Hypertension, February 1, 2002; 39(2): 219 - 223. [Abstract] [Full Text] [PDF]

				S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF]

				J. Ren, L. Jefferson, J. R. Sowers, and R. A. Brown Influence of Age on Contractile Response to Insulin-Like Growth Factor 1 in Ventricular Myocytes From Spontaneously Hypertensive Rats Hypertension, December 1, 1999; 34(6): 1215 - 1222. [Abstract] [Full Text] [PDF]

				M. Silberbach, T. Gorenc, R. E. Hershberger, P. J. S. Stork, P. S. Steyger, and C. T. Roberts Jr. Extracellular Signal-regulated Protein Kinase Activation Is Required for the Anti-hypertrophic Effect of Atrial Natriuretic Factor in Neonatal Rat Ventricular Myocytes J. Biol. Chem., August 27, 1999; 274(35): 24858 - 24864. [Abstract] [Full Text] [PDF]

				M. L Kuroski de Bold Estrogen, natriuretic peptides and the renin-angiotensin system Cardiovasc Res, March 1, 1999; 41(3): 524 - 531. [Abstract] [Full Text] [PDF]

				E. Mascareno, M. Dhar, and M. A. Q. Siddiqui Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: A cellular signal for hypertrophy in cardiac muscle PNAS, May 12, 1998; 95(10): 5590 - 5594. [Abstract] [Full Text] [PDF]

				T. Fujino, N. Hasebe, M. Fujita, K. Takeuchi, J.-i. Kawabe, K. Tobise, S. Higashiyama, N. Taniguchi, and K. Kikuchi Enhanced expression of heparin-binding EGF-like growth factor and its receptor in hypertrophied left ventricle of spontaneously hypertensive rats Cardiovasc Res, May 1, 1998; 38(2): 365 - 374. [Abstract] [Full Text] [PDF]

				Y. Izumi, S. Kim, T. Murakami, S. Yamanaka, and H. Iwao Cardiac Mitogen-Activated Protein Kinase Activities Are Chronically Increased in Stroke-Prone Hypertensive Rats Hypertension, January 1, 1998; 31(1): 50 - 56. [Abstract] [Full Text]

				H. Yu, A. M. Gallagher, P. M. Garfin, and M. P. Printz Prostacyclin Release by Rat Cardiac Fibroblasts : Inhibition of Collagen Expression Hypertension, November 1, 1997; 30(5): 1047 - 1053. [Abstract] [Full Text]

				S. Kim, H. Wanibuchi, A. Hamaguchi, K. Miura, S. Yamanaka, and H. Iwao Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats Hypertension, November 1, 1997; 30(5): 1054 - 1061. [Abstract] [Full Text]

				K. Yagi, S. Kim, H. Wanibuchi, T. Yamashita, Y. Yamamura, and H. Iwao Characteristics of Diabetes, Blood Pressure, and Cardiac and Renal Complications in Otsuka Long-Evans Tokushima Fatty Rats Hypertension, March 1, 1997; 29(3): 728 - 735. [Abstract] [Full Text]